{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:38:37Z","timestamp":1793014717150,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.086","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T01:56:01Z","timestamp":1591926961000},"page":"4964-4969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Estimation of the primary, secondary and composite effects of malaria vaccines using data on multiple clinical malaria episodes"],"prefix":"10.1016","volume":"38","author":[{"given":"Yin Bun","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.F.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.086_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2020.05.086_b0010","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1473-3099(19)30282-8","article-title":"Malaria vaccination and rebound malaria","volume":"19","author":"Dicko","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.086_b0015","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS, S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.05.086_b0020","doi-asserted-by":"crossref","unstructured":"RTS, S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomized, controlled trial. Lancet 2015;386(9988):31\u201345.","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"10.1016\/j.vaccine.2020.05.086_b0025","unstructured":"Joint Technical Expert Group on Malaria Vaccines and World Health Organization Secretariat. Background Paper on the RTS,S\/AS01 Malaria Vaccine. Geneva: World Health Organisation; 2015."},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.086_b0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.vaccine.2008.11.034","article-title":"WHO Malaria Vaccine Advisory Committee. MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials\u2013scientific, regulatory and public health perspectives","volume":"27","author":"Moorthy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.086_b0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/aje\/kwv010","article-title":"Analysis of malaria cohort studies: exploring partial and complete protection, and total and primary intervention effects","volume":"181","author":"Cairns","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.05.086_b0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/sim.3783","article-title":"Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined","volume":"29","author":"Cheung","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.05.086_b0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0169-4758(95)80156-1","article-title":"Will reducing Plasmodium falciparum transmission alter malaria mortality among African children?","volume":"11","author":"Snow","year":"1995","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2020.05.086_b0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1471-4922(00)01814-6","article-title":"Child mortality and malaria transmission intensity in Africa","volume":"17","author":"Smith","year":"2001","journal-title":"Trends Parasitol"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2020.05.086_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2003.68.1","article-title":"Insecticide-treated bednets","volume":"68","author":"Nahlen","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.05.086_b0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12936-015-0805-1","article-title":"Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study","volume":"14","author":"Pemberton-Ross","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2020.05.086_b0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2307\/3214973","article-title":"Models of superinfection and acquired immunity to multiple parasite strains","volume":"33","author":"Milligan","year":"1996","journal-title":"J Appl Probability"},{"key":"10.1016\/j.vaccine.2020.05.086_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0035-9203(95)90419-0","article-title":"Mortality and morbidity from malaria after stopping malaria chemoprophylaxis","volume":"89","author":"Greenwood","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.086_b0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12874-017-0366-9","article-title":"A DAG-based comparison of intervention effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials","volume":"17","author":"Jahn-Eimermacher","year":"2017","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.vaccine.2020.05.086_b0080","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.vaccine.2020.05.086_b0085","series-title":"Modeling survival data: extendingthe cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.vaccine.2020.05.086_b0090","series-title":"Fixed-effects regression models","author":"Allison","year":"2011"},{"key":"10.1016\/j.vaccine.2020.05.086_b0095","series-title":"Analysis of panel data","author":"Hsiao","year":"1986"},{"issue":"20","key":"10.1016\/j.vaccine.2020.05.086_b0100","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/sim.2434","article-title":"Repeated events survival models: the conditional frailty model","volume":"25","author":"Box-Steffensmeier","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.05.086_b0105","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/sim.5458","article-title":"Estimation of summary protective efficacy using a frailty mixture model for recurrent event time data","volume":"31","author":"Xu","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.05.086_b0110","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1128\/IAI.01333-07","article-title":"Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific","volume":"76","author":"Akpogheneta","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.086_b0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bimj.200510217","article-title":"Dynamic analysis of recurrent event data using the additive hazard model","volume":"48","author":"Fosen","year":"2006","journal-title":"Biom J"},{"key":"10.1016\/j.vaccine.2020.05.086_b0120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"issue":"9502","key":"10.1016\/j.vaccine.2020.05.086_b0125","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS, S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.086_b0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/600119","article-title":"Long-term safety and efficacy of the RTS, S\/AS02A malaria vaccine in Mozambican children","volume":"200","author":"Sacarlal","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.086_b0135","series-title":"Statistical models in epidemiology","author":"Clayton","year":"1993"},{"key":"10.1016\/j.vaccine.2020.05.086_b0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1536867X1501500109","article-title":"Frailty models and frailty mixture models for recurrent event times","volume":"15","author":"Xu","year":"2015","journal-title":"Stata J"},{"issue":"9458","key":"10.1016\/j.vaccine.2020.05.086_b0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(05)17860-X","article-title":"Malaria vaccine: 3 or 6 months\u2019 protection?","volume":"365","author":"Smith","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.05.086_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003193","article-title":"What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines","volume":"3","author":"Penny","year":"2008","journal-title":"PLoS ONE"},{"issue":"9741","key":"10.1016\/j.vaccine.2020.05.086_b0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.086_b0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00392-018-1205-7","article-title":"Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints","volume":"107","author":"Rauch","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.vaccine.2020.05.086_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5","article-title":"Survival analysis for recurrent event data: an application to childhood infectious diseases","volume":"19","author":"Kelly","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.05.086_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0962280206071926","article-title":"Wei, Lin and Weissfeld\u2019s marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome?","volume":"16","author":"Metcalfe","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2020.05.086_b0175","unstructured":"Gould W, Pitblado J, Poi B. Maximum likelihood estimation with stata, 4th ed. College Station, TX: StataCorp; 2010."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:25Z","timestamp":1759401865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of the primary, secondary and composite effects of malaria vaccines using data on multiple clinical malaria episodes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}